Does Altered Uric Acid Metabolism Contribute to Diabetic Kidney Disease Pathophysiology?

Current Diabetes Reports
Ambreen Gul, Philip Zager

Abstract

Multiple experimental and clinical studies have identified pathways by which uric acid may facilitate the development and progression of chronic kidney disease (CKD) in people with diabetes. However, it remains uncertain if the association of uric acid with CKD represents a pathogenic effect or merely reflects renal impairment. In contrast to many published reports, a recent Mendelian randomization study did not identify a causal link between uric acid and CKD in people with type 1 diabetes. Two recent multicenter randomized control trials, Preventing Early Renal Function Loss in Diabetes (PERL) and FEbuxostat versus placebo rAndomized controlled Trial regarding reduced renal function in patients with Hyperuricemia complicated by chRonic kidney disease stage 3 (FEATHER), were recently designed to assess if uric acid lowering slows progression of CKD. We review the evidence supporting a role for uric acid in the pathogenesis of CKD in people with diabetes and the putative benefits of uric acid lowering.

References

Dec 19, 1970·Lancet·F StirpeF De Stefano
Jan 5, 2002·Hypertension Research : Official Journal of the Japanese Society of Hypertension·K IsekiS Takishita
May 9, 2002·American Journal of Physiology. Renal Physiology·Marilda MazzaliRichard J Johnson
Nov 22, 2002·Journal of the American Society of Nephrology : JASN·Duk-Hee KangRichard J Johnson
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Joseph V Bonventre, Joel M Weinberg
Jul 16, 2004·Kidney International·John J Friedewald, Hamid Rabb
Sep 24, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kunitoshi IsekiShuichi Takishita
Oct 2, 2004·Kidney International·Todd S PerlsteinNaomi D L Fisher
Apr 21, 2005·Kidney International·Uday M KhoslaRichard J Johnson
Oct 28, 2005·Journal of the American Society of Nephrology : JASN·Duk-Hee KangRichard J Johnson
Dec 27, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Yui-Pong SiuTze-Hoi Kwan
Dec 28, 2006·Hypertension·Eswar KrishnanLewis Kuller
Dec 28, 2006·American Journal of Physiology. Renal Physiology·Laura G Sánchez-LozadaMartha Franco
Mar 3, 2007·Journal of the American Society of Nephrology : JASN·Bruce A PerkinsAndrzej S Krolewski
Nov 6, 2007·Diabetes Care·Abbas DehghanJacqueline C M Witteman
Feb 15, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Elizabeth T RosolowskyAndrzej S Krolewski
Mar 14, 2008·Journal of the American Society of Nephrology : JASN·Daniel E WeinerAndrew S Levey
Apr 25, 2008·Nephron. Physiology·Laura G Sánchez-LozadaRichard J Johnson
Apr 30, 2008·Metabolism: Clinical and Experimental·Michiaki FukuiNaoto Nakamura
May 27, 2008·Metabolism: Clinical and Experimental·Xuemei SuiSteven N Blair
Aug 30, 2008·JAMA : the Journal of the American Medical Association·Daniel I FeigRichard J Johnson
Sep 19, 2008·Journal of the American Society of Nephrology : JASN·Rudolf P ObermayrRenate Klauser-Braun
Oct 24, 2008·The New England Journal of Medicine·Daniel I FeigRichard J Johnson
Feb 25, 2009·Archives of Internal Medicine·Chi-yuan HsuAlan S Go
Mar 24, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Magdalena MaderoVandana Menon
May 22, 2009·American Journal of Physiology. Renal Physiology·Tomoki KosugiTakahiko Nakagawa
Jan 13, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Diana I JalalJanet K Snell-Bergeon
Apr 14, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Gianni BellomoMario Timio
Apr 29, 2010·Current Rheumatology Reports·Marilda MazzaliRichard J Johnson
Jun 12, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Marian GoicoecheaJosé Luño
Jul 28, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Navdeep Tangri, Daniel E Weiner
Dec 21, 2010·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Andrew WheltonLhanoo Gunawardhana
Mar 25, 2011·American Journal of Nephrology·Hiroo SonodaGenjiro Kimura
Oct 18, 2011·Seminars in Nephrology·Naohiko Anzai, Hitoshi Endou
Oct 18, 2011·Seminars in Nephrology·Duk-Hee Kang, Wei Chen
Oct 18, 2011·Seminars in Nephrology·Diana I JalalTakahiko Nakagawa

❮ Previous
Next ❯

Citations

Jun 17, 2020·Experimental and Therapeutic Medicine·Yan-Zi ZhangJi-Hong Chen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.